September 29, 2016 11:52 AM ET


Company Overview of Karyopharm Therapeutics, Inc.

Executive Profile

Michael G. Kauffman M.D., Ph.D.

Co-Founder, Chief Executive Officer and Director, Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Michael G. Kauffman, M.D., Ph.D., co-founded Karyopharm Therapeutics, Inc. in 2008 and has been its Chief Executive Officer since January 5, 2011, Dr. Kauffman served as President at Karyopharm Therapeutics, Inc. from January 2011 to December 2013 and Chief Medical Officer since December 2012 until December 2013. He serves as President of OutlineMed Inc. He served as the Consultant of Onyx Pharmaceuticals, Inc. since December 31, 2010. He served as Clinical Advisor ...

Corporate Headquarters

85 Wells Avenue
Newton, Massachusetts 02459

United States

Phone: 617-658-0600
Fax: --

Board Members Memberships

Co-Founder, Chief Executive Officer and Director
Lead Director, Member of Audit Committee and Member of Compensation Committee


Post-Doctoral Training
Harvard University
Johns Hopkins University
Johns Hopkins University
Amherst College

Other Affiliations

Annual Compensation

Total Annual Compensation$500,000

Stocks Options

All Other Compensation$10,980
Exercisable Options$411,758
Exercisable Options Value$3,226,391
Unexercisable Options$484,302
Unexercisable Options Value$1,840,268
Total Value of Options$5,066,658
Total Number of Options$896,060

Total Compensation

Total Annual Cash Compensation$660,980
Total Short Term Compensation$500,000
Other Long Term Compensation$10,980
Total Calculated Compensation$4,557,480

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Karyopharm Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at